MAY 22, 2020

Grants Awarded   Extramurally funded research grants awarded to Rogel Cancer Center members Program Key: CB - Cancer Biology; CG - Cancer Genetics; CHI - Cancer Hematopoiesis and Immunology; DT - Developmental Therapeutics; HBO - Health Behavior and Outcomes; CEP - Cancer Epidemiology and Prevention; TACR - Translational and Clinical Research

In the spotlight

From Translational and Clinical Research and Developmental Therapeutics

Multi-PI, inter-programmatic, $2.1M R01 awarded by the National Cancer Institute (NCI) to Theodore Lawrence, M.D., Ph.D., FASTRO, FASCO, and Mukesh Nyati, Ph.D., for “Development of a first-in-class mEGFR dimerization inhibitor"

From Cancer Biology

The NCI awarded a $2.5M U01 to Trachette Jackson , Ph.D. for “ Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules"

Costas Lyssiotis, Ph.D., was awarded a $2M R01 from the NCI for "Stromal metabolism promotes therapeutic resistance in pancreatic cancer"

Other $100K+ Grants Awarded in April

Other NIH Anna Mapp, Ph.D. : NIGMS R35 ($2.2M) “Probing transcriptional activation at the molecular level” (DT) Brittany Morgan, Ph.D. (mentor: Anna Mapp, Ph.D. ): NIGMS F32 ($130K) "Molecular Recognition Frameworks for Fuzzy Protein-Protein Interactions" (DT)   Alexey Nesvizhskii, Ph.D. : NIGMS R01 SubK University of Chicago ($280K) “Systematic screening for new histone marks and studying their epigenetic function” (CB)

We want to hear your feedback! Please submit your thoughts about our new internal emails here.

Please forward this message to your fellow cancer center colleagues. They can subscribe to these messages here.

‌ ‌ ‌

M-LINE 800-962-3555 | BLOG michiganhealthlab.org INTRANET  med.umich.edu/i/cancer/index.html